R&D expenditure of new therapeutic drugs 2009-2018

Published by
Matej Mikulic,
Jun 1, 2022
Expected R&D expenditure on new therapeutic agents in the dermatology area averaged at nearly two billion U.S. dollars in the period between 2009 and 2018. This statistic describes the mean and median R&D expenditure for new agents approved by the FDA, by therapeutic area.

Mean and median R&D expenditure on new drugs by therapeutic area between 2009 and 2018* (in million U.S. dollars)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

March 2020

Region

United States

Survey time period

2009 to 2018

Supplementary notes

* Expected expenditure for new therapeutic agents approved by the Food and Drug Administration (FDA).
Therapeutic areas were obtained from the anatomical therapeutic chemical classification system database. Where agents were not yet classified, the categorization was based on the approved indication.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Clinical trials "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Clinical trials

R&D overview

6

Top R&D companies

5

Clinical studies

7

Participation

4

Costs and market

7

Approvals, launches, setbacks

6

COVID-19

4

Further related statistics

20

Further Content: You might find this interesting as well

Statistics

Topics

Clinical trialsGlobal pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsCoronavirus (COVID-19) vaccines and treatments
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu